NO20013862L - Fremgangsmåte for å regulere liposomstörrelse - Google Patents
Fremgangsmåte for å regulere liposomstörrelseInfo
- Publication number
- NO20013862L NO20013862L NO20013862A NO20013862A NO20013862L NO 20013862 L NO20013862 L NO 20013862L NO 20013862 A NO20013862 A NO 20013862A NO 20013862 A NO20013862 A NO 20013862A NO 20013862 L NO20013862 L NO 20013862L
- Authority
- NO
- Norway
- Prior art keywords
- regulating
- solvent
- lipid
- liposome size
- particle size
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Dispersion Chemistry (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pregnancy & Childbirth (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11922999P | 1999-02-08 | 1999-02-08 | |
PCT/US2000/003039 WO2000045791A2 (en) | 1999-02-08 | 2000-02-03 | Method for controlling liposome size |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20013862D0 NO20013862D0 (no) | 2001-08-08 |
NO20013862L true NO20013862L (no) | 2001-10-08 |
Family
ID=22383233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013862A NO20013862L (no) | 1999-02-08 | 2001-08-08 | Fremgangsmåte for å regulere liposomstörrelse |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1150658B1 (zh) |
JP (1) | JP2002536316A (zh) |
KR (1) | KR20010101837A (zh) |
CN (1) | CN1198589C (zh) |
AT (1) | ATE272392T1 (zh) |
AU (1) | AU773515B2 (zh) |
CA (1) | CA2361551A1 (zh) |
DE (1) | DE60012693T2 (zh) |
ES (1) | ES2225094T3 (zh) |
HK (1) | HK1040642A1 (zh) |
HU (1) | HUP0200421A3 (zh) |
IL (2) | IL144756A0 (zh) |
NO (1) | NO20013862L (zh) |
WO (1) | WO2000045791A2 (zh) |
ZA (1) | ZA200106444B (zh) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
EP1585504A4 (en) * | 2002-11-06 | 2009-07-15 | Azaya Therapeutics Inc | LIPOSOMAL PREPARATIONS OF PHARMACEUTICAL AGENTS STABILIZED BY PROTEINS |
CN1812766A (zh) * | 2003-04-25 | 2006-08-02 | 宾州研究基金会 | 用于全身传递使生长停滞的、衍生于脂质的生物活性化合物的方法和*** |
JP2006193461A (ja) * | 2005-01-13 | 2006-07-27 | Pola Chem Ind Inc | 毛髪用の洗浄料 |
KR100684380B1 (ko) * | 2005-05-24 | 2007-02-20 | 한국화학연구원 | 빗살형 폴리에틸렌글리콜을 결합한 리포솜 및 이의 제조방법 |
US8226975B2 (en) | 2005-12-08 | 2012-07-24 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
WO2007117550A2 (en) * | 2006-04-06 | 2007-10-18 | Transave, Inc. | Methods for coacervation induced liposomal encapsulation and formulations thereof |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
EP2317981B1 (en) | 2008-07-24 | 2013-11-13 | Amorepacific Corporation | Multi-layered lamellar granule and skin external application composition containing same |
EP2368627A4 (en) * | 2008-12-24 | 2015-01-14 | Biomedcore Inc | METHOD FOR MANUFACTURING LIPOSOME AND METHOD FOR DISSOLVING CHOLESTEROL |
JP5771366B2 (ja) * | 2009-09-02 | 2015-08-26 | 株式会社バイオメッドコア | リポソーム製造装置及び方法 |
JP5881042B2 (ja) * | 2010-06-23 | 2016-03-09 | 学校法人神奈川大学 | 乳化物製造用親水性ナノ粒子の製造方法 |
KR101130754B1 (ko) * | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
JP6402097B2 (ja) | 2012-05-21 | 2018-10-10 | インスメッド インコーポレイテッド | 肺感染症を処置するためのシステム |
WO2014028087A1 (en) * | 2012-08-17 | 2014-02-20 | University Of Houston | Liposomal formulations of polymyxin and uses thereof |
JP6332902B2 (ja) * | 2012-10-29 | 2018-05-30 | 株式会社ピカソ美化学研究所 | 美容用組成物 |
ES2743039T3 (es) | 2012-11-29 | 2020-02-18 | Insmed Inc | Formulaciones de vancomicina estabilizada |
AU2014318471B2 (en) * | 2013-09-13 | 2019-12-19 | Veiled Therapeutics, Llc | Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation |
SI3142643T1 (sl) | 2014-05-15 | 2019-11-29 | Insmed Inc | Postopki za zdravljenje pljučnih netuberkuloznih mikobakterijskih infekcij |
EP3705179B1 (en) * | 2017-11-01 | 2024-05-22 | Osaka University | Method and system for producing lipid particles having desired particle diameter |
US11571386B2 (en) | 2018-03-30 | 2023-02-07 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
CN114588125B (zh) * | 2022-02-25 | 2023-02-28 | 北京科技大学 | 靶向载药溶栓微泡及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61189215A (ja) * | 1985-02-18 | 1986-08-22 | Teijin Ltd | 5−フルオロ−2′−デオキシウリジンエステル類の油状医薬組成物 |
DE4013580A1 (de) * | 1990-04-24 | 1991-10-31 | Schering Ag | Verfahren zur herstellung von wirkstoffhaltigen waessrigen liposomensuspensionen |
RU2085192C1 (ru) * | 1993-02-03 | 1997-07-27 | Экспериментальное предприятие медико-биологических препаратов Кардиологического научного центра РАМН | Способ получения липосомальной формы альфа-токоферола и гомогенизирующий клапан для его осуществления |
JP3479535B2 (ja) * | 1993-07-08 | 2003-12-15 | ザ リポソーム カンパニー、インコーポレーテッド | リポソームの粒径を制御する方法 |
US5902604A (en) * | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
TWI225412B (en) * | 1997-06-23 | 2004-12-21 | Sequus Pharm Inc | Liposome-entrapped polynucleotide composition and method |
-
2000
- 2000-02-03 KR KR1020017010024A patent/KR20010101837A/ko not_active Application Discontinuation
- 2000-02-03 IL IL14475600A patent/IL144756A0/xx active IP Right Grant
- 2000-02-03 AU AU28718/00A patent/AU773515B2/en not_active Ceased
- 2000-02-03 AT AT00907183T patent/ATE272392T1/de not_active IP Right Cessation
- 2000-02-03 DE DE2000612693 patent/DE60012693T2/de not_active Expired - Fee Related
- 2000-02-03 HU HU0200421A patent/HUP0200421A3/hu unknown
- 2000-02-03 WO PCT/US2000/003039 patent/WO2000045791A2/en not_active Application Discontinuation
- 2000-02-03 CN CNB008035075A patent/CN1198589C/zh not_active Expired - Fee Related
- 2000-02-03 CA CA002361551A patent/CA2361551A1/en not_active Abandoned
- 2000-02-03 ES ES00907183T patent/ES2225094T3/es not_active Expired - Lifetime
- 2000-02-03 EP EP00907183A patent/EP1150658B1/en not_active Expired - Lifetime
- 2000-02-03 JP JP2000596911A patent/JP2002536316A/ja active Pending
-
2001
- 2001-08-06 ZA ZA200106444A patent/ZA200106444B/xx unknown
- 2001-08-06 IL IL144756A patent/IL144756A/en not_active IP Right Cessation
- 2001-08-08 NO NO20013862A patent/NO20013862L/no not_active Application Discontinuation
-
2002
- 2002-04-04 HK HK02102545A patent/HK1040642A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL144756A (en) | 2007-06-03 |
HK1040642A1 (en) | 2002-06-21 |
WO2000045791A3 (en) | 2000-12-21 |
ZA200106444B (en) | 2002-08-06 |
DE60012693D1 (de) | 2004-09-09 |
EP1150658A2 (en) | 2001-11-07 |
ATE272392T1 (de) | 2004-08-15 |
JP2002536316A (ja) | 2002-10-29 |
HUP0200421A3 (en) | 2005-04-28 |
AU2871800A (en) | 2000-08-25 |
WO2000045791A2 (en) | 2000-08-10 |
KR20010101837A (ko) | 2001-11-14 |
CN1198589C (zh) | 2005-04-27 |
AU773515B2 (en) | 2004-05-27 |
CN1338923A (zh) | 2002-03-06 |
NO20013862D0 (no) | 2001-08-08 |
DE60012693T2 (de) | 2005-01-13 |
HUP0200421A2 (en) | 2002-06-29 |
CA2361551A1 (en) | 2000-08-10 |
IL144756A0 (en) | 2002-06-30 |
ES2225094T3 (es) | 2005-03-16 |
EP1150658B1 (en) | 2004-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20013862L (no) | Fremgangsmåte for å regulere liposomstörrelse | |
DK0843547T3 (da) | Fremgangsmåder til at fremstille liposomer, der indeholder hydromonobenzoporphyrin- fotosensibilisatorer | |
DE69938875D1 (zh) | ||
IE801201L (en) | Cementitious product. | |
AU658619B2 (en) | Benzopyranones, methods of manufacture and use thereof | |
AU588101B2 (en) | Machine for unrolling, assembling and laying rolls of pre-cultivated turf | |
BG103251A (en) | Oxydiazols, methods for their preparation and application as medicamentous forms | |
MY115662A (en) | Novel compounds with analgesic effect | |
IN190388B (zh) | ||
MY117090A (en) | Substituted benzamidines, their preparation and their use as pharmaceutical compounds | |
MY135654A (en) | Process for the preparation of a dry pesticidal composition containing a water-soluble salt of glyphosate acid and a dicarboxylate component | |
CA2281744A1 (en) | Emulsifier composition for skin care formulations | |
TR199900814T2 (xx) | Harici kullan�m i�in lokal anestetik. | |
GR3018810T3 (en) | 5,6-dihydroxyindoline as additives for hair-dyeing preparations. | |
CA2133366A1 (en) | Lightweight cement blocks and method of producing same | |
AU9532198A (en) | Ribonucleoside-derivative and method for preparing the same | |
DE69635504D1 (de) | Herstellung von rekombinantem Faktor VIII in Gegenwart von Liposom-ähnliche Verbindung-Zusammensetzungen | |
IE900285L (en) | Peptides with sulphate ester groups. | |
BR9910415A (pt) | Novos compostos, uso de compostos, e, processo de regular a meiose | |
AU3776999A (en) | Biologically-active microdispersion composition | |
IE850185L (en) | Benzopyrans | |
CA2058076A1 (en) | Styrene/maleates terpolymers | |
HUP9802331A2 (hu) | Eljárás méhsejtszerkezetű nedvesség- vagy vízálló, kiterjesztett papír maganyag előállítására és az eljárással kapott méhsejtszerkezetű maganyag | |
ZA825576B (en) | Benzodioxane-imidazoline compounds as antihypertensives | |
IE802418L (en) | ANTIALLERGIC AND ANTIULCER 1-OXO-1H-THIAZOLO (3,2-a)¹PYRIMIDINE-2-CARBOXAMIDES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |